Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 29, 2010

Premium

Arrowhead Research, the parent company of Calando Pharmaceuticals, said that it has appointed Andrew von Eschenbach to its scientific advisory board.

Von Eschenbach was previously commissioner of the US Food and Drug Administration. Before that, he was director of the National Cancer Institute. He currently serves as senior director for strategic initiatives at the Center for Health Transformation, a think tank founded by Newt Gingrich.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.